STEFANIA LAVORATO

Dr. STEFANIA LAVORATO

Universidade Federal do Oeste da Bahia
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Journal of Forensic and Legal Medicine
Verified
Journal Article
Closed access
YCYanna Richelly de Souza Costa
Yanna Richelly de Souza Costa
SLSTEFANIA LAVORATO
STEFANIA LAVORATO
JBJulianna Joanna Carvalho Moraes de Campos Baldin
Julianna Joanna Carvalho Moraes de Campos Baldin

12 February 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Gustavo Villas-BoasGustavo Villas-Boas
Gustavo Villas-Boas
SLSTEFANIA LAVORATO
STEFANIA LAVORATO
MPMarina Meirelles Paes
Marina Meirelles Paes
PCPablinny M. G. de Carvalho
Pablinny M. G. de Carvalho
VRVanessa C. Rescia
Vanessa C. Rescia
SOSilvia Oesterreich
Silvia Oesterreich
Serotonin (5-HT) receptors are found throughout central and peripheral nervous systems, mainly in brain regions involved in the neurobiology of anxiety and depression. 5-HT receptors are currently promising targets for discovering new drugs for treating disorders ranging from migraine to neuropsychiatric upsets, such as anxiety and depression. It is well described in the current literature that the brain expresses seven types of 5-HT receptors comprising eighteen distinct subtypes. In this article, we comprehensively reviewed 5-HT1-7 receptors. Of the eighteen 5-HT receptors known today, thirteen are G protein-coupled receptors (GPCRs) and represent targets for approximately 40% of drugs used in humans. Signaling pathways related to these receptors play a crucial role in neurodevelopment and can be modulated to develop effective therapies to treat anxiety and depression. This review presents the experimental evidence of the modulation of the “serotonergic receptosome” in the treatment of anxiety and depression, as well as demonstrating state-of-the-art research related to phytochemicals and these disorders. In addition, detailed aspects of the pharmacological mechanism of action of all currently known 5-HT receptor families were reviewed. From this review, it will be possible to direct the rational design of drugs towards new therapies that involve signaling via 5-HT receptors.

7 September 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Gustavo Villas-BoasGustavo Villas-Boas
Gustavo Villas-Boas
VRVanessa C. Rescia
Vanessa C. Rescia
MPMarina Meirelles Paes
Marina Meirelles Paes
SLSTEFANIA LAVORATO
STEFANIA LAVORATO
MMManoel F. de Magalhães-Filho
Manoel F. de Magalhães-Filho
SOSilvia Oesterreich
Silvia Oesterreich
On March 11, 2020, the World Health Organization (WHO) officially declared the outbreak caused by the new coronavirus (SARS-CoV-2) a pandemic. The rapid spread of the disease surprised the scientific and medical community. Based on the latest reports, news, and scientific articles published, there is no doubt that the coronavirus has overloaded health systems globally. Practical actions against the recent emergence and rapid expansion of the SARS-CoV-2 require the development and use of tools for discovering new molecular anti-SARS-CoV-2 targets. Thus, this review presents bioinformatics and molecular modeling strategies that aim to assist in the discovery of potential anti-SARS-CoV-2 agents. Besides, we reviewed the relationship between SARS-CoV-2 and innate immunity, since understanding the structures involved in this infection can contribute to the development of new therapeutic targets. Bioinformatics is a technology that assists researchers in coping with diseases by investigating genetic sequencing and seeking structural models of potential molecular targets present in SARS-CoV2. The details provided in this review provide future points of consideration in the field of virology and medical sciences that will contribute to clarifying potential therapeutic targets for anti-SARS-CoV-2 and for understanding the molecular mechanisms responsible for the pathogenesis and virulence of SARS-CoV-2.

15 March 2024 in Bioorganic Chemistry
Verified
Journal Article
Closed access
MPMônica Fraccarolli Pelozo
Mônica Fraccarolli Pelozo
CCCleydson Finotti Cordeiro
Cleydson Finotti Cordeiro
LILetícia Fonseca Inácio
Letícia Fonseca Inácio
RLRayssa de Cassia Alves Lemini
Rayssa de Cassia Alves Lemini
ELElda Gonçalves Souza e Leite
Elda Gonçalves Souza e Leite
LFLucas Lopardi Franco
Lucas Lopardi Franco

8 May 2025 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
KMKátia da Conceição Machado
Kátia da Conceição Machado
JSJurandy Do Nascimento Silva
Jurandy Do Nascimento Silva
DRDébora Caroline Do Nascimento Rodrigues
Débora Caroline Do Nascimento Rodrigues
SLSTEFANIA LAVORATO
STEFANIA LAVORATO
JSJoão Marcelo de Castro e Sousa
João Marcelo de Castro e Sousa
PFPaulo Michel Pinheiro Ferreira
Paulo Michel Pinheiro Ferreira
Non-clinical steps for development, validation and biosafety of new medicines and products comprises studies on cells, proteins, and animals. Herein, we evaluated the toxic activity of antitumoral 2-chloro-N-arylacetamides on eukaryotic dividing cells and animal replacement models. Firstly, the cytotoxicity of chloro (compound 2), bromo (compound 3) and nitro (compound 4) acetamides was analyzed by fluorescent assays in fibroblasts. Next, toxicity was evaluated on Allium cepa meristematic cells and 48h-living Artemia salina larvae. Finally, embryos of Danio rerio (zebrafish) were exposed to the compound 2 (0.14 - 7.2 μg/mL) for 120 h exposure. All arylacetamides were cytotoxic on murine and human fibroblasts, with IC50 values ranging from 1.2 μg/mL (5.6 µM = compound 4 on L-929) to 4.9 μg/mL (24 µM = compound 2 on MRC-5 cells), respectively, and inhibited root growth from 10 to 100 µg/mL, corroborated by mitotic index reduction and cell cycle arrest in interphase (p < 0.05) without clastogenic injuries. Compound 2 showed time- and concentration-dependent killing effects on zebrafish embryos. Its 24 h-acute toxicity at higher concentrations (1.93 and 7.2 μg/mL with 90% and 100% death) corroborated toxicity on aquatic A. salina organisms. After 96 h exposure at 0.52 μg/mL (2.55 µM), almost 100% of the embryos showed more than one lethal/sublethal morphological abnormality (p < 0.05). Then, all arylacetamides showed unspecific toxic effects, mainly the halogenated electrophile chloroacetamide. They present strong antimitotic action on vertebrate and vegetal cells, although such antiproliferative activity does not seem to be directly related to chromosomal damage inductions.

18 October 2024 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
LLLuiz Paulo Melchior de Oliveira Leão
Luiz Paulo Melchior de Oliveira Leão
ANAlbert Katchborian Neto
Albert Katchborian Neto
KNKaren de Jesus Nicácio
Karen de Jesus Nicácio
SLSTEFANIA LAVORATO
STEFANIA LAVORATO
FLFernanda Brito Leite
Fernanda Brito Leite
DDDanielle Dias
Danielle Dias